Outpatient Parenteral Antimicrobial Therapy Plus Buprenorphine for Opioid Use Disorder and Severe Injection-related Infections.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 31342057.
- Also identified by DOI 10.1093/cid/ciz654 and PMC identifier 7931831.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a pilot randomized trial in persons with opioid use disorder hospitalized with injection-related infections, an innovative care model combining outpatient parenteral antimicrobial therapy with buprenorphine treatment had similar clinical and drug use outcomes to usual care (inpatient intravenous antibiotic completion) and shortened hospital length of stay by 23.5 days. NCT03048643.
Medical subject headings
- Anti-Infective Agents
- Buprenorphine
- Opioid-Related Disorders